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ABSTRACT
The Escherichia coli Kl 2 argS MA5002 mutant appears
to have a functionally altered arginyl-tRNA synthetase
(ArgRS). The gene coding for this enzyme was isolated
from E.coli genomic DNA using the PCR procedure and
inserted into a pUC18 multicopy vector. Sequencing
revealed that it differs from the wildtype ArgRS
structural gene only by one mutation: a replacement
of a C by an A residue which results in substitution of
an arginine by a serine at position 134, located two
residues downstream from the HVGH consensus
sequence. As compared to the genomic enzyme level,
this recombinant vector, containing the mutated gene,
produces in E.coli JM103, about 100 times as much
modified ArgRS. This enzyme was obtained nearly pure
after only two chromatographic steps; it exhibits a 4 - 6
times as low activity and a 5 times as high Km value
for ATP as the wildtype enzyme in the aminoacylation
and ATP-PPi reactions; Km values for arginine and
tRNAA'g remained unaltered. The position of this
mutation and its effect on enzymatic properties suggest
the implication of arginine 134 in ATP binding as well
as in the activation catalytic process.
INTRODUCTION
Arginyl-tRNA synthetase like glutamyl- and glutaminyl-tRNA
synthetases differ from the other aminoacyl-tRNA synthetases
in that they require their cognate tRNA to catalyse the ATP-PPi
exchange reaction (1,2). In spite of extensive investigations
performed by several groups, no definitive answer could be
brought so far in favour of one of the two most frequently
proposed mechanisms accounting for this peculiar enzymatic
property: either a two-step mechanism, where tRNA binding is
a prerequisite for adenylate formation (1), or ATP, arginine and
tRNA coreact in a concerted way leading to a one step
aminoacylation of tRNA (3). However some thorough kinetic
investigations (4), such as studies (5) showing that E. coli ArgRS
catalyses the ATP-PPi exchange in the presence of non chargeable
tRNAArg having a 3' terminal deoxyadenosine, support the idea
of a classical two-step mechanism.
Recently we isolated and sequenced the structural gene coding
for E. coli arginyl-tRNA synthetase together with its 247 bp and
399 bp 5' and 3' flanking regions (6). Its amino acid sequence
exhibits no relevant similarities with those of other aminoacyl-
tRNA synthetases except for the presence of an HVGH sequence
homologous to HIGH. This consensus motif, initially identified
by Webster et al. (7), represents one of the most significant
homologies observed up to now between aminoacyl-tRNA
synthetases. In the case of TyrRS from B.stearothernophilus it
was demonstrated that its two flanking histidine residues are
implicated in ATP binding (8,9).
In order to investigate the structure-function relationship in
E. coli ArgRS, we first tried to characterize the mutation described
by Cooper et al. (10). The corresponding mutant (MA 5002)
which was isolated on the basis of its resistance to canavanine,
an inhibitory analogue of arginine , grows more slowly than the
wildype strain in the absence or presence of arginine and exhibits
reduced arginyl-tRNA synthetase activity. To determine the
enzyme mutation(s) responsible for these modifications, we first
isolated the mutated argS gene out of the genomic DNA by the
PCR procedure. The synthesised DNA fragment was inserted
into a pUC18 vector and thorougly sequenced to localize possible
mutations. The transformant strain containing this recombinant
plasmid overproduces mutant ArgRS more than 100 fold as
compared to the wildtype genomic enzyme. This allowed an
efficient purification in a few steps of high amounts of the mutant
enzyme which was analysed for its catalytic parameters.
MATERIALS
Nucleotides, oligonucleotides and DNA
Unfractionated E.coli tRNA was purchased from Boerhinger
Mannheim. 2' deoxy- and 2'3' dideoxynucleoside
5'-triphosphates were from Pharmacia. [a-35S]-dATP (410
Ci/mmole) was from Amersham. Oligonucleotide primers for
sequencing and chain reaction polymerisation were synthesized
on an Applied Biosystems 381A DNA apparatus.
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CsCl purified double stranded plasmidic DNA was prepared
by the alkaline method according to Maniatis et al. ( 1). Rapid
small-scale plasmidic DNA preparation were carried out by the
method of Bimboim and Doly (12). If not specified, DNA
manipulations were performed as described (l1).
Chemicals and enzymes
Taq DNA polymerase from Thermus aquaticus was obtained
from Bioexcellence and Beckman. Modified T7 DNA polymerase
was from Pharmacia, T4 DNA ligase from Boehringer-
Mannheim, and bacterial alkaline phosphatase from Appligene.
[14C]L-arginine was purchased from the CEA (Saclay, France),
HA Ultrogel was from LKB-IBF and DEAE Sephacel from
Pharmacia.
EXPERIMENTAL PROCEDURES AND RESULTS
Transformation and analytical procedures
Transformation of E. coli, agarose and denaturing polyacrylamide
gel electrophoresis, recovery of DNA fragments from agarose
were carried out by standard procedures (l1).
Isolation of the mutated ArgRS gene by enzymatic
amplification
Genomic DNA of the E. coli K12 mutant MA5002 was prepared
according to (13). Synthesis of a 1.9 kbp DNA fragment
containing the gene of ArgRS was conducted directly from its
3' and 5' ends by the PCR procedure in the presence of the
appropriate oligonucleotide primers: the reaction mixture (100
,tl) present in a microcentrifuge tube contained 1 Fg genomic
DNA, 55 mM Tris-HCl pH 8.8 (at 42°C), 16 mM ammonium
sulphate, 5 mM MgCl2, 50 mM KCl, 1 mM of each
deoxynucleoside triphosphate, 2 units of Taq DNA polymerase
and 1 ,uM of primers complementary to each end of the ArgRS
gene and bordered by a HindHI sequence (Figure 1). The mixture
was overlaid with 200 1l of mineral oil (Merck) to prevent
evaporation and transferred to a programmable heat block
(Techne Programmable Dry Block PHC-1). After heating for 4
min at 92°C to denature the genomic DNA, the first primer
annealing step was achieved at 35°C for 2 min to optimize the
number of hybridized molecules, increasing however the
probability of non-specific hybrid formation. The bound primers
were finally extended for 5 minutes at 70°C. The -denaturation,
annealing, extension- cycle was repeated 25 times under the
same conditions except that denaturations were performed for
2 min and hybridizations for 2 min at 62°C: this much more
stringent temperature (to reduce non specific annealing) was
estimated according to the Wallace rule (14) taking into account
the nucleotide composition of the primers. Analysis of a 10 IL
aliquot of the final polymerization mix by agarose gel
electrophoresis (Figure 2) revealed a band whose length (1.9 kbp)
corresponds to that of the expected ArgRS gene. As could be
estimated from the band intensity, more than 1 jig of this specific
fragment was synthesized starting from lAg genomic DNA.
Cloning and sequencing of the amplified fragment
To clone the mutated argS, the amplified 1.9 kbp fragment was
digested by HindlII, purified from PCR components by
electrophoresis on an agarose gel and inserted into the
corresponding site of the dephosphorylated pUC18 vector.
Sequencing of the double stranded plasmidic DNA was
achieved by the dideoxy chain termination method in the presence
AP4
AP2
Af._------------------ AP4
---------------- 90_e
Figure 1: Amplification and sequencing strategy of the argS region.
API: CGCAAGCTTTACGCCACGCGCACGTTGCTGACG;
AP2: CACTGCATGCCGATCGCGTGCTGTATTACATCG;
AP3: ATGCCTGCATCAGGTGTTGATGCTGACGG;
AP4: CGCAAGCTTCTAACCCTGATCAGGCTTCACTCTCACG;
SP5: GCACCTGCTCTGCTAATTGTCGCGGTG;
SP6: ACGATCTGGCCGGTCTGTTC.
Arrows indicate the 5' - 3' orientation of the primers. Primers API and AP4
hybridize to positions - 112 to -89 and 1744 to 1772 respectively with respect
to the first nucleotide of the coding region (6); underlined nucleotides are non
complementary to the wildtype argS sequence and correspond to the recognition
site for the HindIII restriction enzyme. AP2 and AP3 are primers that hybridize
in the central part of the gene, from 980 to 1012 and 1017 and 1045 respectively.
SP5 and SP6 are sequencing primers complementary to positions 160-187 and
1571-1591 respectively. nt, nucleotides.
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Figure 2: Agarose gel electrophoresis of PCR extension products. PCR
amplifications were performed using the oligonucleotide primers described in Fig. 1.
One tenth of the final polymerization mixtures was fractionated on a 1% agarose
gel. Numbers refer to sizes in kbp. Lane a, DNA ladder. Lane b, amplification
of the 1.9 kbp was achieved using primers API and AP4 which create HindIH
sites at both ends (to clone into pUC18 vector). Lanes c and d, the amplification
of the gene was also performed using primers API -4 to produce two DNA
fragments of 0.8 and 1. 15 kbp, overlapping each other on a 50 bp central region
which contains a unique SphI restriction site.
of modified T7 DNA polymerase (15). The whole primary
structures of two cloned inserts coming from different
transformant clones were determined in order to detect among
the mutations those possibly generated during the PCR step. From
sequence comparison it appears that the argS gene from mutant
'l .0
3, ,
areS
00 nt
Nucleic Acids Research 1477
a b c d e
94 kD ow
67 kD --
43 kD
TCTGCGCCAAACGTGGCGAAAGAGATGCATSTCGGTCACCTGCGCTCTACCATSTATTGGTGAC
P N V A K E MLH V H L R S T I I G
Figure 3: Sequences showing the location of the mutation in ArgRS from strain
MA5002. The entire 1.9 kbp HindIm fragment was sequenced using primers 1-6.
The autoradiographs shows sequences of argS from strain MA5002 (B) and
wildtype (A) in the region of the mutation. The position of the mutation is indicated
by an arrow. Below, the mutation is indicated on the mRNA identical DNA strand
and results in a Arg (C) to Ser (A) change at codon 134.
MA5002 differs from the wildtype gene only by one mutation:
a C to A transition in the codon 134 leading to the substitution
of an arginine by a serine (Figure 3).
Purification of the mutated arginyl-tRNA synthetase
About 10% of the crude extract protein prepared from E.coli
JM103 carrying pUC18-1.9 kbp is mutant ArgRS as determined
by immunological titration (16). This more than 100 fold
overproduction compared to the wildtype strain favoured efficient
purification of the plasmidic ArgRS in a few chromatographic
steps: the transformant JM103 pUC18-1.9 kbp was grown at
370C to stationary phase in 6000 ml LB containing 200 itg per
ml ampicillin. Cells were harvested by centrifugation, washed
with 500 ml of 10 mM Tris-HCl pH7.5, 1 mM EDTA,
resuspended in 60 ml of 100 mM Tris-HCl pH 7.5, 10 mM
MgCl2, 1 mM EDTA and finally lysed (20-30 g wet cell paste)
by 6 times sonication for 20 sec at 100 V with an Ultrasons-
Annemasse apparatus (Type 250TS20K). The lysate was cleared
by centrifugation successively at 6000 x g for 30 min and
105,000 x g for 2 hours. Protein concentration was determined
as described (17). The resulting supernatant was loaded onto a
DEAE Sephacel column (id = 5.5 cm, h = 12.5 cm) equilibrated
in 20 mM potassium phosphate buffer pH 7.5. The column was
washed with 250 ml of the same buffer and developed with 1500
ml of potassium phosphate pH 7.5 (20 mM to 500 mM) at a flow
rate of 120 ml/hour. Active fractions were pooled, dialysed
extensively against 10 mM potassium phosphate buffer pH 7.5
and applied to a HA Ultrogel column (id = 2.5 cm, h = 50
cm) equilibrated with the same buffer; then the column was
washed with 200 ml of this last buffer and eluted with 1000 ml
of a linear gradient of potassium phosphate buffer pH 7.5 going
from 10 mM to 50 mM at a flow rate of 60 ml/hour. After this
step, the enzyme (27 mg) was about 95% pure as estimated from
SDS-PAGE (Figure 4).
30 kD
Figure 4: Purification of mutant arginyl-tRNA synthetase from the strain MA5002.
SDS PAGE was carried out according to 23. After electrophoresis, the gel was
stained by Coomassie Blue. Lane a, 30 isg of crude extract from strain MA 5002.
Lane b, 30 Ag of protein from the 105,000 x g supernatant. Lane c, 3 yg of ArgRS
from the DEAE Sephacel fraction. Lane d, 6 Ag of ArgRS from the HA Ultrogel.
Lane e, 4 Ag of the wild type ArgRS prepared as in (6).
Measurements of kinetic parameters
The specific activities of the enzymes in aminoacylation or ATP-
PPi exchange were measured either directly with crude extracts
or with partially purified or pure proteins.
Aminoacylation reaction: A reaction mixture contained 50 mM
Tris-HCl pH7.5, 30 mM KCl, 20 mM MgCl2, 0,1 mM [14-C]L-
arginine (45,000 cpm/nmole), 10 mM ATP, 6 mg/ml
unfractionated E.coli tRNA (it contains about 2% tRNAArg),
5 mM dithio-erythritol, 0.1 mg/ml bovine serum albumin and
appropriate amounts of enzyme. After various incubation times
at 37°C, [l4C]-arginyl-tRNAArg was assayed in 40 pAl of the
reaction mixture by the method described previously (18) and
initial rates were determined. One activity unit is defined as the
amount (in mg) of enzyme which aminoacylates one nanomole
of tRNAArg in one minute under the above conditions. The
measured Vmax and Km values for arginine, ATP and tRNAArg
were respectively 3,500 nmol/min/mg, 11 AM, 4.3 mM and
4.2 /AM for the mutant enzyme and 14,000 nmol/min/mg, 9 AM,
0.7 mM and 3 AM for the native enzyme; these parameters were
determined under the conditions described above except that the
excess of Mg2+ over ATP was maintained constant at 10 mM
in the case of Km measurements for ATP.
ATP-PPi exchange reaction: The standard reaction mixture
contained 100 mM sodium Hepes pH 7.2, 10 mM MgCl2, 2
mM ATP, 2 mM [32p]_ppi (I1-2 cpm/pmole), 5 mM L-
arginine, 10 mM KF (to inhibit pyrophosphatase activity), 12
mg/ml unfractionated E.coli tRNA and enzyme. After various
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incubation times at 37°C, the synthesized [32P]-ATP was
determined in 50 tl aliquots. For Km determinations of ATP
we varied both the concentrations of Mg2+ and ATP, keeping
an excess Mg2+ of 8 mM. The measured Vmax and Km values
for arginine, ATP were respectively 9400 nmol/min/mg, 0.11
mM and 11 mM in the case of the mutant enzyme and 56,000
nmol/min/mg, 0.15 mM and 2 mM for the native enzyme.
Thus it appears that the mutation only affects the enzyme
activity and the ATP kinetic parameters and this at nearly the
same level in both reaction.
DISCUSSION
As compared to other aminoacyl-tRNA synthetases, the study
of the structure-function relationship of ArgRS is of peculiar
interest since one of its catalytic properties, the ATP-PPi
exchange reaction requires the presence of tRNAArg to take
place; this substrate interacts probably with the corresponding
catalytic activation site to maintain it in a functional conformation.
In addition, it may be noticed that the relative small size of the
enzyme, its monomeric structure and the availability of a
previously engineered ArgRS overproducing strain, are
favourable prerequisites for crystal production and X-ray
structural investigation of the enzyme.
To localize functional domains of ArgRS we favoured an
approach which consists in measuring the effect induced by
polypeptide chain modifications on the catalytic parameters. This
led us to first analyse a mutant described earlier by Cooper et
al. (10) which, as they showed, exhibits modified enzymatic
properties relative to ArgRS.
The gene coding for the mutant enzyme was isolated from
genomic E. coli DNA by the PCR method as a 1.9 kbp fragment
that was inserted into a pUC18 plasmid. This in vitro technique
for primer directed enzymatic amplification of specific DNA
sequences is capable of synthesizing over a million copies of a
specific target DNA sequence. It represents a form of in vitro
molecular cloning that can accomplish, in an automated 3-step
reaction, what otherwise takes days or weeks of biological
growth, screening and biochemical purification. However it has
to be tioticed that in order to successfully apply this method,
special attention has to be paid to the choice of the primer-
template hybridization temperature. As was the case in our study,
the determination of the optimal value of this critical parameter
often requires several preliminary tests.
The recombinant pUC18 plasmid containing the mutant ArgRS
gene expressed this enzyme at a level corresponding to about
10% of the total amount of the crude extract proteins. This
favoured rapid isolation of the enzyme that was nearly pure after
two chromatographic steps. Sequencing of the whole double
stranded mutant structural gene ofArgRS revealed that a unique
mutation was present which consisted in substitution of an
arginine at position 134 by a serine. It appears that this mutation
is located two residues downstream from a HIGH consensus box
motif which, as demonstrated in the case of TyrRS from
B.stearothennophilus, is implicated by both its histidine residues
respectively in ATP binding and stabilization of the adenylate
transition complex (8, 9). Although this consensus sequence is
located in a much more central position (129-132) in ArgRS
as compared to the other aminoacyl-tRNA synthetases, its
functional identity can be assumed by considering the effect of
the mutation at the adjacent position 134 on enzymatic properties:
as was shown from kinetic investigations, this modification didn't
affect the Km values neither for arginine nor for the tRNAArg
measured in the aminoacylation and activation reactions. However
the mutation increases the Km value for ATP from 0.7 to 3.8
mM and lowers the Vmax of the aminoacylation reaction by a
factor about 4; nearly the same variations were obtained for these
parameters in the exchange reaction suggesting that the mutation
modifies in fact only the rate of the activation step, the observed
decrease in the aminoacylation Vmax beeing probably due to a
rate dependent effect.
The modification of the catalytic properties induced by the
mutation should result in an important drop of the aminoacylation
efficiency in vivo; indeed if we assume that in E. coli the total
ATP concentration is about 2 mM (19), the mutant enzyme will
be about 2.5 times less saturated than the native one (as can be
calculated from ATP Km values determined in aminoacylation
as well in the exchange reaction). Furthermore if we take into
account a 4 times lower aminoacylation activity, the mutant
ArgRS will be at least 10 times (2.5 x4) less active in vivo than
the wildtype protein. This is well consistent with the low growth
rate observed for the MA 5002 mutant strain.
Futhermore, as it appears from the Vmax values, the wildtype
ArgRS compared to the mutant enzyme exhibits lower activation
energy in both reaction steps; this let us to conclude that the
increment of ATP binding energy due to arginine 134 is realized
in stabilization of the enzyme transition state rather than the
enzyme ATP complex. In the activation as well as in the
aminoacylation step a binding energy variation of about 2 kcal,
which corresponds to that of a hydrogen bond, can be calculated
according to the formula developed by Fersht (20) taking into
account both the kcat and Km values for mutant and wildtype
enzymes.
The question may be raised as to whether this higher binding
energy, due to the presence of an arginine residue at position
134 near the HVGH motif, reflects the existence of a direct
interaction of this amino acid with ATP, or is the consequence
of an indirect effect which improves the efficiency of the ATP
binding domain. If we consider the tertiary structure of the
equivalent HIGH domain in TyrRS from B. stearothermophilus
(21) and E.coli MetRS (22) we observe that the position
corresponding to arginine 134 in these enzymes (2 residues
downstream from the HIGH) is located in an cx helix; this
structural element connected with an adjacent (3 strand constitutes,
as demonstrated (21), the seat of ATP binding and amino acid
activation.
Provided, as it may be reasonably assumed, that the HVGH
structural context of ArgRS is homologous to that of the previous
enzymes, it is more than likely that arginine 134, due to the length
of its side chain which confers him a wide potential interaction
area, may interact with residues located in the catalytical
activation site as well as the bound ATP substrate; in the case
of MetRS we could show by modelling, using the FRODO
programme, that an arginine located two residues away from the
HIGH motif in MetRS from E.coli, has several possibilities to
establish several hydrogen bonds with ATP. Studies concerning
further investigations of this point and more generally the
localization of other functional domains are now in progress by
site directed mutagenesis.
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